Type 2 immune responses to allergens and other environmental factors, including T H 2 cell cytokine responses and production of IgE antibodies, are key immunologic features of allergic diseases.
T H 2-type CD4
1 T cells and type 2 innate lymphoid cells that produce IL-4, IL-5, and IL-13 have been considered major players in directing the pathophysiology of allergic disease, including airway eosinophilia, mucosal hyperplasia, and airway remodeling.
1,2 However, our knowledge regarding the immunologic mechanisms that regulate IgE antibody production is limited. Traditionally, T H 2 cells are expected to play a critical role 3 because they produce IL-4, a key cytokine that regulates IgE class-switching. 4 Considerable heterogeneity exists in the clinical phenotypes and genetic contributions to allergic diseases. For example, not all patients with asthma have IgE antibodies to allergens, and not all patients with detectable serum IgE antibody levels experience asthma. 5, 6 A genome-wide association study identified a link between asthma/airway eosinophilia and single nucleotide polymorphisms in IL1RL1, IL18R, IL33, TSLP, and RORA. 7 In contrast, associations between serum IgE levels and single nucleotide polymorphisms in FCER1A, IL13, STAT6, and IL4R/IL21R were identified, but very few genes commonly associated with both serum IgE level and asthma. 7 Thus the fundamental question of whether T H 2-type cytokine responses and IgE antibody production are regulated by the same immunologic pathway remains unanswered.
Follicular helper T (T FH ) cells are distinguished from other CD4
1 T H cells through their selective role in orchestrating germinal center (GC) responses and in promoting the development of memory B cells and long-lived plasma cells. 8, 9 In mice immunized systemically by means of intraperitoneal injection of ovalbumin (OVA) plus alum adjuvant, a positive correlation between the development of IL-4-secreting T FH cells and the production of IgE and IgG 1 antibodies was observed. 10 Furthermore, IL-4-secreting T FH cells mediated class-switching and affinity maturation of IgE and IgG 1 in the lymph nodes of mice infected with the parasites Leishmania major and Nippostrongylus brasiliensis. 11 Other studies involving Schistosoma mansoni and Heligmosomoides polygyrus also demonstrated the production of IL-4 by T FH cells. 12, 13 However, information regarding the contribution of T FH cells to the regulation of IgE antibodies in allergic immune responses to airborne allergens remains limited.
Accordingly, to better understand the development of CD4 1 Tcell subsets in response to inhaled allergens and to elucidate their roles in allergic immune responses, we used mouse models of airway allergen exposure. Our observations suggest a critical role for T FH cells in the regulation of IgE antibody production. Hence allergic immune responses might be mediated by T FH and T H 2 cells, which are 2 distinct subsets of IL-4-producing CD4 1 T cells.
METHODS

Fluorescence-activated cell-sorting analyses of mLN and lung cells
Anterior and posterior mLNs from each mouse were harvested and pooled. Single-cell lung suspensions were prepared by digesting harvested lungs with a cocktail of collagenases in the presence of DNase, as described previously. 15 The mLN cells and single-cell lung suspensions were preincubated with Fc receptor blockers for 30 minutes at 48C and stained with combinations of antibodies and analyzed by gating on lymphocytic cells by using a FACSCalibur flow cytometer (BD Biosciences Immunocytometry Systems). See the Methods section in this article's Online Repository for a list of antibodies and details regarding analysis strategies.
Gene expression analyses
Day 11 mLN cells from 4get mice exposed to OVA plus IL-33 were enriched for CD4 1 populations were sorted with a FACSAria flow cytometer (BD Biosciences). Cells were lysed in Trizol (Invitrogen, Carlsbad, Calif), and total RNA was extracted and purified with the PureLink RNA Mini Kit (Thermo Fisher Scientific, Minneapolis, Minn), followed by microarray and quantitative RT-PCR (qRT-PCR) analyses.
Cytokine production in vitro
Day 11 mLN cells were isolated, washed, and cultured in RPMI 1640 medium with 10% calf serum, 100 mg/mL streptomycin, and 100 U/mL penicillin (complete RPMI) at a density of 4 3 10 5 cells/200 mL/well in a roundbottom 96-well tissue-culture plate for 4 days. OVAwas added at a concentration of 100 mg/mL. Alternatively, day 11 mLN cells were enriched for CD4 1 Adoptive transfer
, and CD3
1 cell populations from the donor C57BL/6 mice were sorted, as described above. The recipient Tcrb 2/2 mice were administered OVA plus IL-33 intranasally on days 0 and 7 and injected with 75,000 sorted cells intravenously 1 day after first exposure to OVA plus IL-33 (day 1). On days 21, 22, and 23, recipient mice were challenged intranasally with 100 mg of OVA alone. Plasma was collected for analysis of specific antibodies on days 14, 24, and 49. In other experiments similar cell populations were sorted and injected into Il7r 2/2 mice at a concentration of 150,000 cells per mouse. The recipient mice were exposed to OVA plus IL-33 on days 0, 3, and 6 and assessed for airway inflammation on day 8.
RESULTS
IL-33 promotes development of 2 distinct subsets of IL-4-competent CD4 1 T cells in draining lymph nodes
Respiratory exposure to innocuous proteins generally induces immune tolerance. 17 Recently, airway epithelial cells that produce innate cytokines, such as IL-1a, IL-25, IL-33, and thymic stromal lymphopoietin, and that promote T H 2-type immunity were implicated in asthma and allergic diseases. 18 Furthermore, members of the IL-1 family of cytokines have been shown to overcome suppression by regulatory T cells and to promote functional differentiation of T cells. 19 To better understand the mechanisms involved in the development of T H 2-type immunity to airborne allergens, we exposed the airways of naive BALB/c mice to endotoxin-free OVA with or without IL-1b or IL-33 twice through intranasal administration (Fig 1, A) . Subsequently, we examined the production of type 2 cytokines in draining mLNs on day 11 and plasma antibody levels resentation of a mouse airway sensitization model. Naive 4get mice (BALB/c background) were exposed intranasally to OVA with or without IL-1b or IL-33. B, On day 14, plasma was analyzed for anti-OVA antibodies (Ab) by means of ELISA. *P < .05 and **P < .01 compared with mice exposed to OVA alone. #P < .05 compared with mice exposed to OVA plus IL-33. Data are presented as means 6 SEMs (n 5 4-5 in each group). C, Day 11 mLN cells were cultured with or without OVA. Cytokine levels in supernatants were analyzed by mean of ELISA. #P < .05 compared with OVA plus IL-33. Data are presented as means 6 SEMs (n 5 4-5 in each group). D-G, Day 11 mLN cells were gated on lymphocytes, and expression of CD4, IL-4eGFP, ST2, and CXCR5 was analyzed by means of FACS. Fig 1, D , Representative scattergrams showing expression of CD4 and IL-4eGFP in a total lymphocyte population and expression of ST2 and on day 14. As expected, exposure to OVA alone resulted in negligible plasma anti-OVA antibody levels (Fig 1, B) . Similarly, intranasal administration of IL-1b or IL-33 alone did not have a remarkable effect on anti-OVA antibody levels (data not shown).
In contrast, when animals were exposed to OVA in conjunction with IL-1b, plasma levels of anti-OVA IgE and IgG 1 , another immunoglobulin isotype related to T H 2-type immunity, 20 increased significantly (P < .01); however, no increase in levels of the IgG 2a isotype were observed. Likewise, administration of OVA and IL-33 promoted the production of anti-OVA IgE and IgG 1 , but levels were slightly lower than those induced by OVA plus IL-1b (P < .05).
When cultured in vitro with OVA antigen, mLN cells from the mice exposed to OVA plus IL-1b produced IL-4 and IL-13 but only minimal IL-5 (Fig 1, C) . In contrast, mLN cells from the mice exposed to OVA plus IL-33 exhibited robust production of all 3 type 2 cytokines. Furthermore, the concentrations of IL-13 produced by mLN cells from mice exposed to OVA plus IL-33 were significantly higher than the corresponding IL-13 levels produced by mLN cells from mice exposed to OVA plus IL-1b (P < .05). However, the IL-4 concentrations produced by mLN cells from mice exposed to OVA plus IL-33 and from mice exposed to OVA plus IL-1b were comparable. When mice previously exposed to OVA plus IL-33 were challenged intranasally with OVA alone, they had marked airway eosinophilia and increased levels of IL-5 and IL-13 in bronchoalveolar lavage (BAL) fluids. 21 In contrast, mice previously exposed to OVA plus IL-1b produced modest airway eosinophilia and lower BAL levels of IL-5 and IL-13.
These findings led us to hypothesize that 2 or more subsets of T H 2-like CD4 1 T cells with similar capacities to produce IL-4 but distinct IL-5 and IL-13 production might be involved. T H 2 and T FH cells are among the CD4 1 T cells known to produce IL-4. 11, 22 To characterize IL-4-producing cells, we exposed 4get IL-4 reporter mice 23 intranasally to OVA plus IL-1b or IL-33 by using the same protocol described in Fig 1, A, and analyzed mLN cells on day 11. In 4get mice an internal ribosomal entry site and downstream eGFP are inserted at the 39 end of Il4, which allows identification of cells that actively transcribe the IL-4 locus. Consequently, IL-4eGFP
1
CD4
1 T cells were clearly detectable in mLNs from mice exposed to OVA plus IL-1b or OVA plus IL-33 (Fig 1, D and E) .
The IL-33 receptor ST2 and the chemokine receptor CXCR5 are considered reliable markers for differentiated T H 2 cells 24 
CXCR5
1 cells were IL-4eGFP 1 after administration of a low (1 ng) IL-33 dose (Fig 1, F and G 
CD4
1 T cells as the control. The comparison of gene expression profiles revealed sets of genes that were unique to each population and not expressed by other populations (Fig 2,  A and B) . For example, ST2
1 CXCR5 2 cells expressed T H 2 cell markers, including Gata3, Il5, Il13, and Prdm1 (encoding Blimp-1), as well as Il6, receptors for certain chemokines and lipid mediators, and integrins (Fig 2, C) 
CXCR5
2 cells, which were verified by using real-time quantitative RT-PCR (qRT-PCR; Fig 2, D) . In addition, qRT-PCR analyses also revealed that Gata3 was expressed most highly by ST2 
Gata3
Bcl6 Rorc Representative genes in each group are presented by using the criteria described in the Table. Fig 2, D, mRNA expression of select genes was analyzed by means of qRT-PCR, and results were normalized to 18s RNA levels and expressed as a ratio to the CD4 1 IL-4eGFP 2 population (mean 6 SEM, n 5 4). *P < .05 and **P < .01 between the groups indicated by horizontal lines. E and F, Naive BALB/c mice were exposed intranasally to OVA plus IL-33, as described in Fig 1, A. Day 11 mLN cells were sorted into
, and CD3 (APCs), to examine cytokine production (Fig 2, E) . We used the entire population of CD4 1 T cells as the source for cell sorting so that we could obtain sufficient cell numbers for culture (see 
CXCR5
2 cells (Fig 2, F) . In addition, a significantly higher amount of IL-13 was produced by ST2
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2 cells than by ST2
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1 cells, but the reverse was the case for IL-21. Interestingly, when B cells isolated from the spleens of naive mice were used as APCs, the ST2 
ST2
2 CXCR5
1 cells were T FH cells specialized for the production of IL-4 and IL-21.
Isolated T H 2 and T FH cells preferentially mediate allergic airway inflammation and IgE antibody production, respectively
The stimulation of B cells by IL-4, together with other signals, leads to class-switch recombination to IgE. 20 Furthermore, conventional models predict that T H 2-type CD4 1 T cells serve as a major source of IL-4 for B-cell production of IgE antibody. 3, 27 Therefore to compare the capacity of T H 2 and T FH cells to mediate IgE antibody production, we chose an adoptive transfer approach. We isolated T H 2 cells (CD4
1 ) from C57BL/6 mice previously exposed to OVA plus IL-33 and transferred them intravenously to naive T cell-deficient Tcrb 2/2 mice (C57BL/6 background) with an intact B compartment (Fig 3, A) . 28 In the absence of T transferred cells, Tcrb 2/2 mice were unable to produce detectable levels of anti-OVA IgE or IgG 1 antibody (Fig 3, B) . However, when T H 2 cells from mice exposed intranasally to OVA plus . B, Plasma antibody levels were analyzed by means of ELISA. Results are means 6 SEMs (n 5 3 in each group). **P < .01 compared with mice that received T H 2 cells. C, Schematic representation of an adoptive transfer model to Il7 2/2 mice (C57BL/6 background). D and E, BAL fluids were analyzed for cytokine levels (Fig 3, D) and inflammatory cell numbers (Fig 3, E) . Results are means 6 SEMs (n 5 3 in each group). **P < .01 between groups indicated by horizontal lines. Fig 3, B, D , and E, are representative of 2 separate experiments. Eos, Eosinophils; i.n., intranasal; Lym, lymphocytes; Mac, macrophages; Neu, neutrophils.
IL-33 were transferred to Tcrb 2/2 mice, the mice produced anti-OVA IgE antibody, but the levels decreased after day 24. When T FH cells were transferred to Tcrb 2/2 mice, the mice exhibited robust production of anti-OVA IgE antibody, and the levels were maintained up to at least day 49. IgG 1 anti-OVA isotype antibody levels in the mice continued to increase after transfer of either T H 2 or T FH cells, but IgG 2a antibody did not achieve detectable levels.
To compare the roles of T H 2 and T FH cells in airway inflammation, we used mice deficient in the IL-7 receptor a chain (Il7r 2/2 ; C57BL/6 background) as recipients (Fig 3, C) . IL-33 can activate innate immune cells, such as type 2 innate lymphoid cells, which makes it difficult to interpret the contributions of T cells to airway inflammation, but Il7r 2/2 mice lack ILCs. 2 As expected, naive Il7r 2/2 mice produced no detectable levels of cytokines when challenged intranasally with OVA plus IL-33 without T-cell transfer. However, Il7r 2/2 mice that received T H 2 cells and were challenged intranasally with OVA plus IL-33 produced marked levels of type 2 cytokines in BAL fluids (Fig 3, D) and had profound airway eosinophilia (Fig 3, E) . Conversely, no inflammatory responses were observed in Il7r 2/2 mice that received T FH cells. 4get mice previously exposed to OVA plus IL-33 were challenged intranasally with OVA antigen to compare the anatomic location of T H 2 and T FH cells during type 2 immune responses (Fig 4, A) . A large number of T H 2 cells were localized in lung tissues and BAL fluids, and some were detectable in mLNs (Fig 4, B and C) . In contrast, T FH cells remained in mLNs, even after antigen challenge, whereas only a limited number were identified in lung tissues or BAL fluids. These findings suggested that T H 2 cells were mobile and mediated type 2 cytokine production and inflammation in the airways. In contrast, the T FH cells remained in the draining lymph nodes and likely contributed to the sustained production of IgE antibody.
Airway exposure to natural allergens induces T FH and T H 2 cells
The initial experiments used IL-1 family cytokines as an adjuvant to induce the development and differentiation of CD4 1 T cells; however, doses of these cytokines might have exceeded those observed in a physiologic setting. IL-4-competent T FH cells have been previously reported in mice infected with helminth parasites. [11] [12] [13] Therefore to examine the roles of T H 2 and T FH cells in allergic airway responses in a physiologic setting, we sought to use naturally occurring allergens implicated in human allergic airway diseases, including a fungus belonging to the genus Alternaria, the cockroach and HDM, and the cysteine protease bromelain as a generic model for protease allergens. [29] [30] [31] Naive 4get mice were exposed intranasally to allergen extracts twice without any adjuvants or exogenous cytokines (Fig 5, A) .
IL-4-competent CD4
1 T cells (IL-4eGFP
1
CD4
1 T cells) were clearly detected in mLNs of mice exposed to these allergens (Fig 5, B) . Among the allergens tested, the Alternaria alternata extract induced the largest numbers of IL-4eGFP 1 cells (Fig 5,  C) . Conversely, the cockroach extract yielded relatively small effects. A large proportion of IL-4eGFP 1 cells (up to 55%) demonstrated an ST2
2
CXCR5
1 phenotype (Fig 5, B and C) , which suggested that airway exposure of naive mice to natural allergens triggered T FH cell development. ST2
1
CXCR5
2 T H 2 cells were also detected in mice exposed to Alternaria alternata, HDM, or bromelain, although to a lesser extent than T FH cells. Interestingly, bromelain induced a larger proportion of T H 2 cells relative to T FH cells compared with the other allergen extracts, which suggested that the nature of the allergens affected the differential development of T FH and T H 2 cells.
T FH cells are diminished by genetic depletion of Bcl6 in CD4
1 T cells
Because the Alternaria alternata extract induced the largest numbers of both T FH and T H 2 cells among the allergens, we selected Alternaria alternata as a model for subsequent experiments aimed at defining the roles of these cell types in allergic immune responses. The transcriptional repressor BCL6 is considered the master regulator for the T FH cell lineage. 32, 33 However, germline Bcl6 knockout mice had spontaneous inflammation, most likely because of the proinflammatory phenotype of Bcl6-deficient myeloid cells. 34, 35 To investigate the specific roles of T FH cells, we used a floxed Bcl6 mouse model in which Bcl6 was conditionally depleted in OVA+IL-33 i.n. Cd4-Cre mice).
14,36 These mice appeared normal and exhibited no apparent signs of disease (data not shown), and the thymus and spleen contained normal T-cell numbers and CD4 and CD8 populations. 14 We exposed Bcl6 fl/fl Cd4-Cre mice intranasally to Alternaria alternata extract spiked with 100 mg of OVA (Fig 6, A) . OVA was included to allow us to monitor antigen-specific immune responses without relying on endogenous Alternaria alternata proteins that are often unstable and often present in variable concentrations in natural allergen extracts. 37 When exposed to Alternaria alternata plus OVA, Bcl6 fl/fl mice lacking CD4-Cre had both ST2 (Fig 6, B and C) . Furthermore, the T FH cell population was abolished in Bcl6 (Fig 6, D and E) . Nonetheless, a marked decrease in the frequency and total number of FAS 1 peanut agglutinin (PNA) 1 GC B cells was observed in Bcl6 fl/fl Cd4-Cre mice. To examine whether the antigen-specific effector functions of T H 2 cells were affected by Bcl6 deficiency, we restimulated mLN cells with the OVA antigen in vitro. After stimulation with OVA, mLN cells from Bcl6 fl/fl mice (no CD4-Cre) produced IL-4, IL-5, and IL-13 (Fig 6, F) ) were initially exposed intranasally to Alternaria alternata extract with OVA and then re-exposed intranasally to the OVA antigen alone to investigate the roles of T FH cells in allergic immune responses to inhaled allergens (Fig 7, A) . As expected, Bcl6 fl/fl mice that were only exposed to OVA did not have antibodies at any time point (Fig 7, B) . When initially exposed to Alternaria alternata extract plus OVA, Bcl6 fl/fl mice had anti-OVA IgE antibodies by day 14, which was sustained until at least day 35. In contrast, anti-OVA IgE antibodies were nearly undetectable in however, no differences were observed in plasma concentrations of total IgA and IgM. Mice were re-exposed to OVA intranasally on days 42 through 44 to examine the production of type 2 cytokines and inflammation in the respiratory mucosa. Bcl6 fl/fl mice previously exposed to OVA alone and subsequently re-exposed to OVA did not exhibit increases in type 2 cytokines in the lung tissues (Fig 7, C) or any signs of airway inflammation (Fig 7, D) . When initially exposed to Alternaria alternata extract plus OVA and then reexposed to OVA, Bcl6 fl/fl mice displayed increased levels of IL-5 and IL-13 in the lungs and marked airway eosinophilia.
Bcl6
fl/fl Cd4-Cre mice also showed comparable increases in these cytokines and airway eosinophilia, which suggested that T FH cells are required for IgE antibody production but unnecessary for airway inflammation.
To verify this concept, we used a different genetic model. The interaction between inducible costimulator (ICOS) and ICOS fl/fl mice previously exposed to OVA alone. ##P < .01 compared with Bcl6 fl/fl mice previously exposed to Alternaria alternata extract plus OVA. Data are presented as means 6 SEMs (n 5 5 in each group). C and D, Cytokine levels in lung homogenates (Fig 7, C) and numbers of inflammatory cells in BAL fluids (Fig 7, D) were analyzed on day 45. In Fig 7, C and D , results are presented as means 6 SEMs (n 5 5 in each group). *P < .05 and **P < .01 between the groups indicated by horizontal lines. Data are representative of 2 separate experiments. Eos, Eosinophils; i.n., intranasal; Lym, lymphocytes; Mac, macrophages; Neu, neutrophils.
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 ligand plays a critical role in T FH cell differentiation. 33, 38 Therefore we subjected wild-type (WT) C57BL/6 mice or germline Icos-deficient mice (Icos
2/2
) to an experimental protocol that was similar to the one described above for Bcl6 fl/fl Cd4-Cre mice (see Fig E5, A, in this article's Online Repository at www. jacionline.org). Partial but significant decreases in ST2
2
CXCR5
1 T FH cell numbers were observed in Icos 2/2 mice compared with WT mice (P < .05; see Fig E5, B and C) , but the number of ST2
1
CXCR5
2 T H 2 cells was not affected. Furthermore, when CD4 1 T cells from Icos 2/2 mice were restimulated with OVA in vitro, the cells produced IL-5 and IL-13 (see Fig E5, D) , and the cytokine levels were higher compared with those from WT mice. In contrast, plasma levels of anti-OVA IgE and IgG 1 antibodies were markedly reduced in Icos 2/2 mice (see Fig E5, E) .
OX40 ligand contributes to type 2 cytokine responses and airway inflammation but not to development of T FH cells or IgE antibody production
The prior observations led us to speculate that unlike a conventional model, the 2 key components of allergic immune responses, which are IgE antibody production and type 2 cytokine responses, could be independently regulated by 2 subsets of IL-4-producing CD4
1 T cells. To test this concept from a different angle, we sought a model in which the terminal differentiation of T H 2 cells was impaired but T FH cells were unaffected.
OX40 ligand, a TNF family ligand that is the product of Tnfsf4, has been shown to play a role in the development of pathologic T H 2 cells, which are capable of mediating strong type 2 inflammatory responses in mice. 39 When exposed intranasally to the Alternaria alternata extract plus OVA, numbers of ST2 ) were comparable with those of WT C57BL/6 mice (Fig 8, A and B) . Nonetheless, production of IL-4, IL-5, and IL-13 by T cells from Tnfsf4 2/2 mice was minimal after in vitro stimulation with OVA, which suggested that the effector functions of T H 2 cells were impaired (Fig 8, C ; P < .05). In addition, when challenged with OVA in vivo (Fig 8,  D) , Tnfsf4 2/2 mice displayed significantly lower levels of IL-4 and IL-13 in the lungs compared with WT mice (Fig 8, E ; P < .05 and P < .01, respectively), and airway eosinophilia was nearly abolished (Fig 8, F) . In contrast, Tnfsf4 2/2 mice had robust anti-OVA IgE and IgG 1 antibodies compared with corresponding levels observed in WT mice (Fig 8, G) .
DISCUSSION
In the current study we exposed the airways of naive mice to cytokines and natural allergens and examined the development of adaptive type 2 immune responses. A novel concept derived from this study was that 2 major components of allergic immune responses, IgE antibody production and type 2 cytokine responses, were regulated separately by T FH and T H 2 cells in vivo.
The conventional model suggests that T H 2-type CD4 1 T cells play key roles in various features of allergic immune responses, including IgE antibody production, production of type 2 cytokines, airway eosinophilia, and mucosal hyperplasia. 3, 27 Our findings not only suggested that T FH cells were necessary for IgE antibody production but also that T FH cells were sufficient even when canonical T H 2 cells were absent or their effector functions were compromised. In contrast, T H 2 cells played major roles in type 2 cytokine production and eosinophilic airway inflammation, even in the absence of T FH cells or IgE antibodies, which suggested that T FH and T H 2 cells play distinct roles in allergic immune responses.
As shown in Fig 2, T H 2 and T FH cells were clearly distinguishable by their expression of key transcription factors and cell-surface molecules and by the production of IL-5, IL-13, and IL-21. Furthermore, no overlap was detected between T H 2 and T FH cell populations when the phenotypes of IL-4eGFP 1 cells were examined by using fluorescence-activated cell sorting (FACS) with ST2 and CXCR5 as markers (Fig 1) . Furthermore, T H 2 cells were mobilized to the lungs and airways during allergic immune responses, whereas T FH cells remained in the draining lymph nodes (Fig 4) . These observations were consistent with an earlier study involving a Nippostrongylus brasiliensis infection model that demonstrated distinctive tissue localization of T H 2 cells (expressing both Il4 and Il13) and T FH cells (expressing Il13 but not Il4).
22 Therefore the likelihood exists that allergic immune responses consist of 2 distinct subsets of IL-4-producing CD4
1 T cells, each of which demonstrates unique phenotype, localization, and effector functions, as summarized in Fig E6 in this article's Online Repository at www.jacionline.org. By extension of this concept, it is tempting to speculate that certain human allergic diseases might involve T FH cells rather than T H 2 cells. Examples would be allergic diseases involving demonstrated roles for IgE antibodies and minimal signs of mucosal inflammation, such as food allergies and anaphylaxis.
IL-4-producing T FH cells were previously described in mice infected with L major or various helminth parasites [11] [12] [13] 22 and in mice immunized systemically by injection of OVA plus alum. 10 Our observations contributed to this knowledge by demonstrating that exposure of the airways of naive BALB/c or C57BL/6 mice to natural allergens, such as Alternaria alternata and HDM, induced IL-4-production by T FH cells. Furthermore, the proportions of T FH and T H 2 cells generated were dependent on the allergen. Nonetheless, questions remain regarding the immunologic mechanisms involved in the development of T FH cells after allergen exposure. Previously, IL-6 and IL-21 were shown to induce T FH cells in vitro. Specifically, CD4
1 T cells cultured with IL-6 or IL-21 expressed BCL6 and/or CXCR5 mRNA in a signal transducer and activator of transcription 3-dependent manner. 33, 40 However, the mechanisms of T FH cell development in vivo appear to be rather complex. Il6
, and Il21r 2/2 mice, as well as Stat3-deficient mice, exhibited no or minimal defects in T FH cell development. [41] [42] [43] However, the blockage of IL-6 in Il21 2/2 mice and Il6/Il21 double-knockout mice resulted in a partial decrease in T FH cell numbners. 44, 45 In this study we found that the combined intranasal administration of IL-33 or IL-1b and OVA effectively induced IL-4-competent T FH cells, which suggested an alternative method for the generation of T FH cells in vivo in the absence of infectious agents. However, mice lacking specific receptors, including IL-1R1 (receptor for IL-1a and IL-1b) or IL-1RL1 (ST2, receptor for IL-33), had levels of IgE antibody that were comparable with those of WT animals (data not shown). Hence there appears to be considerable redundancy in the T FH development pathway. This speculation is further supported by the observation that although only IL-33 effectively induced T H 2 cells (Fig 1) , T (n 5 4 in each group). C, mLN cells were cultured with or without OVA, and cytokine levels in supernatants were analyzed by means of ELISA. Results are means 6 SEMs (n 5 5-7 in each group). *P < .05 between the groups indicated by horizontal lines. Data are representative of 2 separate experiments. D, Schematic representation of a mouse airway sensitization and challenge model. E and F, Cytokine levels in lung homogenates (Fig 7, E) and numbers of inflammatory cells in BAL fluids (Fig 7, F) were analyzed on day 25. Results are means 6 SEMs (n 5 5-7 in each group). *P < .05 and **P < .01 between the groups indicated by horizontal lines. G, Plasma levels of anti-OVA IgE, IgG 1 , and IgG 2a antibodies were analyzed by means of ELISA. *P < .05 and **P < .01 between groups indicated by horizontal lines. Data are presented as means 6 SEMs (n 5 5-7 in each group). In Fig 8, C, E , F, and G, data are a pool of 2 separate experiments. Eos, Eosinophils; i.n., intranasal; Lym, lymphocytes; Mac, macrophages; Neu, neutrophils.
At the molecular level, our mouse allergy models verified critical roles for BCL6 and ICOS in the development of T FH cells in vivo. BCL6 is considered the master regulator for T FH differentiation 32, 33 because it inhibits the differentiation of other CD4 1 Tcell subsets through repression of the transcription factor Blimp1. 32 Germline Bcl6 2/2 mice have spontaneous inflammatory diseases. 34, 35 The use of Cd4-driven Cre recombinase in Bcl6-floxed mice allowed us to determine that the deficiency of Bcl6 in the CD4 1 T-cell compartment resulted in nearly complete depletion of T FH cells in vivo (Fig 6) , but it did not induce systemic inflammation. Numbers of ST2 1 mature T H 2 cells were not affected in these mice, but production of type 2 cytokines was enhanced, which reflected the capacity of BCL6 to inhibit GATA3 expression and T H 2 cell differentiation. 47 ICOS has been shown to play an important role in the development and effector functions of T FH cells and various other T-cell subsets, including T H 1, T H 2, T H 17, and regulatory T cells. 48 Mice deficient in ICOS signaling consistently displayed decreased serum levels of IgE and IgG 1 . [49] [50] [51] [52] ICOS has also been shown to promote the expansion of T H 2 cells, 53, 54 which provides a potential mechanistic basis for decreased IgE levels, although the results are controversial. 50, 55 In this study Icos 2/2 mice exhibited marked decreases in T FH cell numbers compared with WT mice when exposed to airborne allergens, which was consistent with previous findings. 11, 33, 38 However, these mice paradoxically exhibited enhanced T H 2-type cytokine responses. The differences in our results and some previous observations could be explained by differences in the models, including adjuvants used and routes of antigen administration. Nonetheless, ICOS signaling is critical for Bcl6 expression 38 ; thus it was expected that ICOS deficiency could result in a phenocopy of Bcl6 deficiency in CD4
1 T cells. Notwithstanding, BCL6 and ICOS likely served as a molecular switch and played a role in determining whether naive CD4
1 T cells differentiated into T FH or T H 2 cells. It has been established that IL-4 and its downstream signaling molecules are required for the class-switch recombination of IgE antibody in vitro and in vivo. 56 In our model T FH and T H 2 cells from day 11 mLNs were both capable of producing IL-4 when they were restimulated with antigen in vitro, despite the fact that the Il4 regulatory mechanisms in T FH and T H 2 cells appear distinct. 10, 22 We also found that adoptive transfer of either T FH or T H 2 cells induced production of IgE and IgG 1 antibodies (Fig 3) . Importantly, production of IgE antibodies induced by transfer of T FH cells was sustained for at least 4 weeks after the final antigenic stimulation; however, the IgE response induced by T H 2 cells was relatively transient. Nonetheless, sustained increases in IgG 1 antibody levels were observed after transfer of either T FH or T H 2 cells.
Previous studies involving the injection of mice with a goat antibody to mouse IgD indicated that T-cell help exclusive of IL-4 production was important for the generation of an IgE response but not for an IgG 1 response. 57 Hence T FH cells might provide signals other than IL-4 for optimized and sustained IgE production, perhaps through a direct physical interaction with B cells or the release of additional soluble factors. IL-21, which is abundantly produced by T FH cells, 9 could be a candidate factor. Nonetheless, the roles of IL-21 in IgE antibody production are rather controversial. For example, IL-21 induced 58 or inhibited 59, 60 IgE antibody production in vitro. In an in vivo study IL-21 receptor-deficient mice produced even higher levels of IgE. 61 Alternatively, any molecules that are identified by means of microarray analyses as unique to T FH cells (Fig 2) , such as PD-1, signaling lymphocyte activation molecule-associated protein, B-and T-lymphocyte attenuator, or a combination of these molecules, could play a comparable role. Accordingly, additional studies aimed at identifying critical molecules provided by T FH cells, which are involved in the sustained production of IgE antibodies during allergic immune responses, are required.
Given our observations, the robust and unique characteristics of T FH cells in the mediation of IgE antibody production might explain the pathophysiology of various IgE-dependent allergic diseases, such as food allergies and anaphylaxis. Recognizing the involvement of T FH and T H 2 cells, which are 2 distinct subsets of IL-4-producing CD4 1 T cells (see Fig E6) , could aid in redefining the mechanisms involved in allergic diseases. Nonetheless, achieving a better understanding of the molecular and immunologic mechanisms involved in the differentiation and function of T FH cells and methods to disrupt these pathways will be of central importance in the development of new treatment and preventive strategies for allergic diseases. 
Antigens, allergens, and recombinant cytokines
Recombinant IL-33 (R&D Systems, Minneapolis, Minn, or eBioscience, San Diego, Calif) and IL-1b (R&D Systems) contained less than 1.0 EU/mg endotoxin. Alternaria alternata, cockroach, and HDM extracts were obtained from Greer Laboratories (Lenoir, NC). Alternaria alternata and HDM extracts contained undetectable levels of endotoxin (<10 ng/mg extract). Bromelain was obtained from Sigma-Aldrich (St Louis, Mo).
Mouse airway exposure and challenge model
On days 0 and 7, naive mice were lightly anesthetized with tribromoethanol or isoflurane and administered 100 mg of OVA administered intranasally in the presence or absence of 100 ng or serial dilutions of IL-33 or IL-1b in 50 mL of endotoxin-free PBS. On day 11, the mice were killed by an overdose of pentobarbital, and mLNs were collected. In some experiments mice were exposed intranasally to Alternaria alternata (50 mg), cockroach (50 mg), or HDM (400 mg) extracts; bromelain (10 mg); or Alternaria alternata (50 mg) plus OVA (10 mg). Some mice were then challenged intranasally with 100 mg of OVA by using the protocols described in the figure legends.
Plasma antibody levels
Plasma levels of OVA-specific IgE, IgG 1 , and IgG 2a were measured by means of ELISA, as previously described.
E1 Total IgE, IgG 1 , IgM, and IgA levels were measured by means of ELISA in accordance with recommended protocols with antibodies from BD Biosciences.
FACS analyses of mLN cells and lung cells
The mLN cells and single-cell lung suspensions were preincubated with Fc receptor blockers for 30 minutes at 48C and stained with combinations of phycoerythrin-conjugated anti-CXCR5 (clone 2G8) or anti-PD-1 (J43), peridinin-chlorophyll-protein complex2conjugated anti-CD4 (L3T4) and/or biotin-conjugated anti-ST2 (DJ8; MD Biosciences, St Paul, Minn), or anti-CXCR5, followed by streptavidin-allophycocyanin. In some experiments cells were fixed, permeabilized, and stained with anti2Ki-67 antibody. To analyze GC B cells, the cells were stained with fluorescein isothiocyanate2conjugated PNA (Vector Laboratories, Burlingame, Calif), peridinin-chlorophyll-protein complex2conjugated anti-B220 (RA3-6B2), and biotin-conjugated anti-CD95 (FAS; Jo2), followed by streptavidin-allophycocyanin. After washing, the cells were resuspended in PBS containing 1% BSA and 0.1% NaN 3 , fixed with 1% paraformaldehyde, and analyzed by using a FACSCalibur flow cytometer (BD Biosciences Immunocytometry Systems). The lymphocytic cell population was gated by using a forward-and side-scatter plot. Antibodies were obtained from BD Biosciences, unless otherwise described.
Gene expression analyses
For microarray analysis, sample preparation, labeling, and array hybridizations (Affymetrix GeneChip Mouse Genome 430 2.0 Array; Affymetrix, Santa Clara, Calif) were performed by using standard Mayo Clinic Advanced Genomic Technology Center Gene Expression Core Facility protocols.
qRT-PCR analyses were performed, as previously described (Kouzaki et al, 2009) E2 with slight modifications. Briefly, cDNAs were synthesized with an iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, Calif). The real-time PCR contained cDNA, TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, Calif), and TaqMan gene expression assays for the following target genes: Gata3 (Mm0048683_m1), Bcl6 (Mm00477633_m1), Rorc (Mm01261019_g1), Il4 (Mm00445259_m1), Il5 (Mm00439646_m1), Il13 (Mm00434204_m1), Il21 (Mm00517640_m1), and 18S (Hs99999901_s1; Applied Biosystems). The transcription levels were normalized to 18S rRNA in each sample and expressed relative to CD4
1 IL-4eGFP 2 cells.
Cytokine production in vitro T cells by using anti-CD3-coated magnetic beads (STEMCELL Technologies) at a 1:3 ratio in the presence of 100 mg/mL OVA for 7 days. Concentrations of IL-4, IL-5, IL-13, and IL-21 in the supernatants of the culture medium were analyzed by means of ELISA, according to the manufacturer's recommended procedures (R&D Systems).
Analyses of airway inflammation
To collect BAL fluids, the trachea was cannulated, and lavage was performed in triplicate with HBSS (0.5, 0.25, and 0.25 mL, respectively). Cell numbers were counted, and differentials were determined in cytospin preparations stained with Wright-Giemsa stain. More than 200 cells were counted by using conventional morphologic criteria. The BAL fluid supernatants were collected and stored at 2208C for cytokine assays. In some experiments supernatants from lung tissue homogenates were prepared and assayed for total protein and cytokine expression. E3 IL-4, IL-5, IL-13, and IL-17 concentrations in BAL fluid and lung homogenate supernatants were analyzed by means of ELISA, as described above.
Statistical analysis
Data are presented as means 6 SEMs for the numbers of mice or experiments indicated. The statistical significance of differences between the various treatment groups was assessed by using a Student t test, and a P value of less than .05 was considered statistically significant.
FIG E1.
Antibody production in mice exposed to OVA with different doses of IL-33. Naive BALB/c mice were exposed intranasally to 100 mg of OVA plus 0, 1, 10, or 100 ng of IL-33 on days 0 and 7. On day 14, plasma levels of anti-OVA IgE, IgG 1 , and IgG 2a antibodies were analyzed by means of ELISA. **P < .01 compared with OVA plus no IL-33. 
FIG E3.
T-cell populations sorted for cell culture (Fig 2, E and F) and adoptive transfer (Fig 3) experiments. Naive WT C57BL/6 or BALB/c mice were exposed intranasally to OVA plus IL-33 on days 0 and 7. 
